Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-11-29Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia in Individuals With Higher Risk of Transplant Failure
-
CLINICAL_TRIALS study record update · 2024-11-27Prediction of Adverse Outcomes in Pregnancies of Individuals With Sickle Cell Disease - SCRIPT: Sickle Cell Risk in Pregnancy Tool
-
CLINICAL_TRIALS study record update · 2024-11-25Early HLA Matched Sibling Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease: a Sickle Transplant Advocacy and Research Alliance (STAR) Trial
-
CLINICAL_TRIALS study record update · 2024-11-22A Phase 1, Open-Label, Two-Part, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Effect of Voxelotor on the Pharmacokinetics of Selected CYP and Transporter Probe Substrates in Healthy Participants
-
CLINICAL_TRIALS study record update · 2024-11-20An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-20Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
-
CLINICAL_TRIALS study record update · 2024-11-19Age of Blood in Sickle Cell Transfusion -The Effects of Phosphotidylserine Expression on Older Red Cell Units in Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2024-11-18The Use of Intranasal (IN) Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the Pediatric Emergency Department
-
CLINICAL_TRIALS study record update · 2024-11-15The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy
-
CLINICAL_TRIALS study record update · 2024-11-14FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
-
CLINICAL_TRIALS study record update · 2024-11-05Lentiviral Vector Gene Therapy in Sickle Cell Disease Using Autologous CD34+ Hematopoietic Stem Cells Collected Via Apheresis and Modified With a Lentiviral Vector
-
CLINICAL_TRIALS study record update · 2024-10-30Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia
-
CLINICAL_TRIALS study record update · 2024-10-29Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
-
CLINICAL_TRIALS study record update · 2024-10-29SEG-2022-01 Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers
-
CLINICAL_TRIALS study record update · 2024-10-29Disease Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery (GRNDaD) Registry
-
CLINICAL_TRIALS study record update · 2024-10-28Use of Heart Rate Variability (HRV) Biofeedback for Symptom Management Among Sickle Cell Patients: Pilot Intervention
-
CLINICAL_TRIALS study record update · 2024-10-28A Prospective Open Label, Pharmacokinetic Study of an Oral Hydroxyurea Solution in Children With Sickle Cell Anemia.
-
CLINICAL_TRIALS study record update · 2024-10-24Pre-Transplant Immunosuppression and Related Haploidentical Hematopoietic Cell Transplantation for Patients With Severe Hemoglobinopathies
-
CLINICAL_TRIALS study record update · 2024-10-08A Phase 1/2 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the LentiGlobin BB305 Lentiviral Vector in Subjects With Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2024-09-24A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults With Severe Sickle Cell Disease (BMT CTN 1503)
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Characterize the Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2024-09-03LCI-HEM-SCD-ST3P-UP-001: A Comparative Effectiveness Study of Peer Mentoring [PM] Versus Structured Transition Education Based Intervention [STE] for the Management of Care Transitions in Emerging Adults With Sickle Cell Disease (SCD)
-
CLINICAL_TRIALS study record update · 2024-08-30Ketorolac Dosing for Acute Vaso-Occlusive Crisis in Pediatric Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2024-08-27ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
-
CLINICAL_TRIALS study record update · 2024-08-23Early Identification and Intervention Of Developmental Delay Among Infants And Toddlers With Sickle Cell Disease Using the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention